Importantly, oral ALPI supplementation protected ALPI‐deficient mice from increased susceptibility to DSS‐induced colitis (Ramasamy et al, 2011) and from chronic colitis induced by recurrent non‐lethal infections by S. typhimurium (Yang et al, 2017). This evidence concerns the gene ALPI and colitis.